#obesity-treatment

[ follow ]
#weight-loss
Wearables
fromwww.mercurynews.com
1 month ago

Zepbound trims more belly fat than Wegovy, study shows

Eli Lilly's Zepbound outperformed Novo Nordisk's Wegovy in a recent study, showing superior weight loss and waist circumference reduction.
Wearables
fromBusiness Insider
1 month ago

Weight loss in a pill? Eli Lilly just took a big step closer to making it happen

Orforglipron, a new oral GLP-1 drug from Eli Lilly, may transform obesity treatment by offering a non-injection alternative.
fromWIRED
7 hours ago
Alternative medicine

A New Obesity Pill May Burn Fat Without Suppressing Appetite

Wearables
fromwww.mercurynews.com
1 month ago

Zepbound trims more belly fat than Wegovy, study shows

Eli Lilly's Zepbound outperformed Novo Nordisk's Wegovy in a recent study, showing superior weight loss and waist circumference reduction.
Wearables
fromBusiness Insider
1 month ago

Weight loss in a pill? Eli Lilly just took a big step closer to making it happen

Orforglipron, a new oral GLP-1 drug from Eli Lilly, may transform obesity treatment by offering a non-injection alternative.
fromWIRED
7 hours ago
Alternative medicine

A New Obesity Pill May Burn Fat Without Suppressing Appetite

more#weight-loss
fromNature
5 days ago

How to keep weight off after obesity drugs

Sheree's struggle emphasizes the increasing reliance on non-traditional methods for weight management amidst the challenges presented by GLP-1 therapies.
Alternative medicine
#diabetes
OMG science
fromHarvard Gazette
1 month ago

How a fishing expedition helped lead to GLP-1 - Harvard Gazette

GLP-1's discovery has revolutionized the treatment of obesity and diabetes.
Unexpected research paths can lead to significant medical advancements.
fromFuturism
1 month ago
NYC startup

Eli Lilly's New Weight Loss Drug May Have the Worst Name in Pharmaceutical History

OMG science
fromHarvard Gazette
1 month ago

How a fishing expedition helped lead to GLP-1 - Harvard Gazette

GLP-1's discovery has revolutionized the treatment of obesity and diabetes.
Unexpected research paths can lead to significant medical advancements.
fromFuturism
1 month ago
NYC startup

Eli Lilly's New Weight Loss Drug May Have the Worst Name in Pharmaceutical History

more#diabetes
#ozempic
Alternative medicine
fromenglish.elpais.com
1 month ago

The Ozempic universe expands: These drugs also treat fatty liver disease

Ozempic drugs show promise in treating fatty liver disease, halting or reversing its progression, and may provide broader therapeutic effects beyond weight loss.
more#ozempic
#clinical-trials
Wearables
fromwww.nytimes.com
1 month ago

What to Know About Eli Lilly's Daily Pill for Weight Loss

Eli Lilly's orforglipron offers a potential oral treatment for obesity and diabetes, expanding access beyond current injected options.
Wearables
fromtime.com
2 months ago

Pfizer Ends Development of Its Obesity Pill

Pfizer has halted the development of danuglipron due to safety concerns, but remains committed to exploring other obesity treatment options.
Wearables
fromwww.nytimes.com
1 month ago

What to Know About Eli Lilly's Daily Pill for Weight Loss

Eli Lilly's orforglipron offers a potential oral treatment for obesity and diabetes, expanding access beyond current injected options.
Wearables
fromtime.com
2 months ago

Pfizer Ends Development of Its Obesity Pill

Pfizer has halted the development of danuglipron due to safety concerns, but remains committed to exploring other obesity treatment options.
more#clinical-trials
#healthcare-policy
Healthcare
fromFast Company
2 months ago

Trump scraps Biden's plan to cover Wegovy and Zepbound through Medicare

Trump administration's decision excludes expensive obesity treatments from Medicare coverage.
Medicine
fromtime.com
2 months ago

Medicare Will Not Cover GLP-1 Drugs for Weight Loss

Medicare and Medicaid will not cover weight-loss drugs for obesity treatment, affecting millions.
Healthcare
fromFast Company
2 months ago

Trump scraps Biden's plan to cover Wegovy and Zepbound through Medicare

Trump administration's decision excludes expensive obesity treatments from Medicare coverage.
Medicine
fromtime.com
2 months ago

Medicare Will Not Cover GLP-1 Drugs for Weight Loss

Medicare and Medicaid will not cover weight-loss drugs for obesity treatment, affecting millions.
more#healthcare-policy
#medicare
Healthcare
fromwww.mercurynews.com
3 months ago

Patients struggle with lack of consistent coverage for popular weight-loss drugs

Access to obesity treatments is hindered by inconsistent insurance coverage and high costs, making it difficult for many to maintain weight loss.
fromwww.nytimes.com
2 months ago
Medicine

Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugs

Trump administration rejects Biden's proposal on obesity drug coverage for Medicare and Medicaid.
Healthcare
fromwww.mercurynews.com
3 months ago

Patients struggle with lack of consistent coverage for popular weight-loss drugs

Access to obesity treatments is hindered by inconsistent insurance coverage and high costs, making it difficult for many to maintain weight loss.
Medicine
fromwww.nytimes.com
2 months ago

Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugs

Trump administration rejects Biden's proposal on obesity drug coverage for Medicare and Medicaid.
more#medicare
#tirzepatide
more#tirzepatide
Healthcare
fromwww.npr.org
3 months ago

Consumers can buy Zepbound direct from the drugmaker if they'll pay out of pocket

Eli Lilly's Zepbound reaches 100,000 direct buyers monthly, showing a shift towards online drug sales despite insurance coverage limitations.
#health-research
US news
fromBoston.com
4 months ago

Could obesity drugs help with alcohol cravings? New study suggests potential

GLP-1 receptor agonists show potential in reducing alcohol cravings but safety for non-obese individuals remains uncertain.
US news
fromBoston.com
4 months ago

Could obesity drugs help with alcohol cravings? New study suggests potential

GLP-1 receptor agonists show potential in reducing alcohol cravings but safety for non-obese individuals remains uncertain.
more#health-research
#zepbound
more#zepbound
[ Load more ]